Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CellSense Technologies is a Berlin-based life science tools company that develops and manufactures advanced Brillouin microscopy systems for mechanobiology research. Its products are used to measure the mechanical properties of biological samples such as organelles, cells, organoids, tissues, biomaterials, and small organisms in a non-invasive, label-free manner. The company positions Brillouin microscopy as an enabling platform for both basic and translational research across cell biology, biomedicine, tissue engineering, pharmacology, and cancer research. CellSense appears to be focused on commercial instrument sales and application support rather than therapeutic drug development. Its flagship commercial offering is the Discoverer Brillouin microscope platform, designed to integrate with established research microscope workflows.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CellSense Technologies.